Oritavancin

ATC J01XA05 · 6 markets · 9 records

Oritavancin 6 markets · 9 records Forms

CA 2 records · 2 strengths

1,200 mgpowderORITINIV
400 mgpowderORITINIV

ES 2 records · 2 strengths

400 mginjectionTENKASI also in US·GB
1,200 mginjectionTENKASI also in FR

FR 2 records · 2 strengths

1,200 mginjectionTENKASI 1200 mg, poudre pour solution à diluer pour perfusion also in ES
443.7 mginjectionTENKASI 1200 mg, poudre pour solution à diluer pour perfusion

US 1 records · 1 strengths

400 mginjectionOrbactiv also in ES·GB

GB 1 records · 1 strengths

400 mginjectionTenkasi 400mg powder for concentrate for solution for infusion vials also in ES·US

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名TENKASI ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.